MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$5,320.505K
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Research and development
4,766.832
3,487.247
2,589.749
1,730
General and administrative
1,877.831
1,738.006
1,503.326
1,504.295
Total operating expenses
6,644.663
5,225.253
4,093.074
3,234.295
Income (loss) from operations
-6,644.663
-5,225.253
-4,093.074
-3,234.295
Other income (loss)
32.158
-
0
-
Interest income (loss)
1,299.205
1,332.203
655.473
780.769
Net income (loss)
-5,313.3
-3,893.05
-3,437.601
-2,453.526
Foreign currency translation gain (loss), net
0.516
-0.19
-0.116
-3.456
Unrealized gain (loss) on investments, net
-7.721
-32.678
-65.763
102.817
Comprehensive income (loss)
-5,320.505
-3,925.918
-3,503.48
-2,354.165
Basic EPS
-0.62
-0.46
-0.48
-0.35
Basic Average Shares
8,542,450
8,535,443
7,123,849
6,998,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive income (loss)
-$5,320.505K
(-126.00%↓ Y/Y)
Foreign currency
translation gain (loss), net
$0.516K
(114.93%↑ Y/Y)
Net income (loss)
-$5,313.3K
(-116.56%↓ Y/Y)
Unrealized gain (loss) on
investments, net
-$7.721K
(-107.51%↓ Y/Y)
Interest income (loss)
$1,299.205K
(66.40%↑ Y/Y)
Other income (loss)
$32.158K
Income (loss) from
operations
-$6,644.663K
(-105.44%↓ Y/Y)
Total operating
expenses
$6,644.663K
(105.44%↑ Y/Y)
Research and development
$4,766.832K
(175.54%↑ Y/Y)
General and
administrative
$1,877.831K
(24.83%↑ Y/Y)
Buy us a coffee
Monopar Therapeutics (MNPR)
Monopar Therapeutics (MNPR)